Learn More
Medchemexpress LLC (S)-3-cyclopropyl-4,7,7-trimethyl-4-phenyl-2,4,6,7,8,9-hexahydro-pyrazolo[3,4-b]quinolin-5-one | 1597439-87-6 | 99.6% | 347.45 g/mol | C22H25N3O | 100 MG

Supplier: Medchemexpress LLC HY117822100MG
BRD0209 is a potent, reversible ATP-competitive inhibitor of glycogen synthase kinase 3 alpha and beta (GSK3α/β) with low-nanomolar potency. Provided as a high-purity solid for research use, it is suitable for in vitro biochemical assays, cell-based studies, and compound screening.
- Potent GSK3α/β inhibition (GSK3α IC50 = 19 nM; GSK3β IC50 = 5 nM).
- High purity for reliable assay performance.
- Solid form with defined storage recommendations for stability.
- Supplied as a 100 mg quantity for laboratory use.
- Suitable for biochemical and cell-based research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.